News tagged with b cell lymphoma
A better target for B-cell lymphomas: From a library of MAG antagonists to nanomolar CD22 ligands
Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20.
Oct 25, 2011 |
not rated yet |
0
|
Study reveals how fusion protein triggers cancer
What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts.
Jan 27, 2011 |
4.3 / 5 (3) |
1
|
Patent awarded for method to dampen immune response
National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department ...
Medicine & Health / Medical research
Jan 18, 2011 |
not rated yet |
1
Scientists identify possible gene target for treating a form of lymphoma
Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor. Mutation of the MYD88 gene was found to be one of the most frequent ...
Dec 22, 2010 |
not rated yet |
0
New mutation linked to non-Hodgkin's lymphoma
Some patients with non-Hodgkin lymphoma (NHL) -- a cancer of B cells -- harbor a particular mutation in the gene encoding the receptor for B cell activating factor (BAFF), according to a paper published online on November ...
Nov 01, 2010 |
not rated yet |
0
Scientists find new way to attack cancerous cells
Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.
Jun 07, 2010 |
5 / 5 (11) |
0
|
Small molecule targets B cell lymphoma
Scientists are one step closer to developing a targeted therapy for lymphoma. New research, published by Cell Press in the April 13th issue of the journal Cancer Cell, identifies a specific small-molecule inhibitor that w ...
Apr 12, 2010 |
5 / 5 (2) |
0
Scientists announce advance in understanding body's natural defenses
Medical Research Council (MRC) scientists at the University of Leicester have made a new advance in understanding how the body fights certain types of cancer and other disease such as Lupus and rheumatoid arthritis.
Medicine & Health / Medical research
Mar 11, 2010 |
not rated yet |
0
What is the function of the protein CD20?
Antibodies directed against the protein CD20, which is expressed by immune cells known as B cells, are used to treat B cell non-Hodgkin lymphoma and rheumatoid arthritis. Despite this, the function of CD20 has not been determined. ...
Medicine & Health / Medical research
Dec 22, 2009 |
not rated yet |
0
A new target for lymphoma therapy
Researchers at the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI) have found a link between a common mutation that can lead to cancer and ...
Dec 09, 2009 |
not rated yet |
0
Microsoft co-founder Allen treated for lymphoma
(AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy.
Nov 17, 2009 |
not rated yet |
0
Researchers find new way to attack inflammation in Graves' eye disease
A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms — and improved vision — following treatment with the drug rituximab. Inflammation around their eyes and damage to the ...
Medicine & Health / Diseases, Conditions, Syndromes
Nov 06, 2009 |
not rated yet |
0
New therapy for vasculitis will help patients avoid infertility and cancer
Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, ...
Medicine & Health / Diseases, Conditions, Syndromes
Oct 18, 2009 |
not rated yet |
0
Experimental drug lets B cells live and lymphoma cells die
(PhysOrg.com) -- An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental He ...
Medicine & Health / Medical research
Sep 21, 2009 |
not rated yet |
0
Protein complex key in avoiding DNA repair mistakes, cancer
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.
Aug 05, 2009 |
4.7 / 5 (3) |
0
